IP Library Granted Patent US 10,137,077
Granted Patent B2
US 10,137,077 · App. 15/107,000 · Granted Nov 27, 2018

Cosmetic use of

Inventors: Jean-Marie Botto (Garbejaïre, FR); Valère Busuttil (Nice, FR); Karine Cucumel (Opio, FR); Neil Astles (Nice, FR); Nouha Domloge (Valbonne, FR)
Assignee: ISP Investments, LLC
A61K8/987A61K8/97A61K35/612A61Q17/00A61Q19/00A61K2800/591
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,137,077
App. No.
15/107,000
Granted
Nov 27, 2018
Kind
B2
Abstract

Methods of protecting skin from damage due to cold thermal stress are disclosed. The methods include topically applying a composition that includes an Artemia salina extract from rehydrated Artemia salina cysts to skin at risk of damage from thermal stress, particularly from cold thermal stress or repeated temperature variations. The composition includes a physiologically acceptable medium for delivery of the Artemia salina extract.

Claims (8)

1. A method of cosmetic care to protect the skin of a human or animal from damage due to cold thermal stress, the method comprising:

topically applying at least once or twice daily for at least two days, on at least one portion of the skin of the body or face of the human or animal which has been subjected to cold thermal stress, a composition comprising a physiologically acceptable medium and an Artemia salina extract obtained from rehydrated Artemia salina cysts,

wherein the Artemia salina extract is present in the composition at a concentration of about 0.0001% to about 20% of the total weight of the composition, and the cells of the at least one portion of skin of the body or face of the human or animal maintain a physiological level of cold-inducible RNA-binding protein.

2. The cosmetic care method according to claim 1 , wherein said Artemia salina extract is diluted in one or more physiologically suitable solvents, chosen from among water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycol, ethoxylated diglycol or propoxylated diglycol, cyclic polyols or any mixture of these solvents.

3. The cosmetic care method according to claim 1 , wherein said Artemia salina extract is present at a concentration of about 0.05% to about 5% of the total weight of the composition.

4. The cosmetic care method according to claim 1 , wherein the composition further comprises at least one additional active agent chosen from among vitamin A, retinoic acid, retinol, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin E, vitamin F, vitamin H, vitamin K, vitamin PP, coenzyme Q10, metalloproteinase inhibitors, amino acids, carnitine, carnosine, taurine, natural or synthetic peptides, vegetable peptide extracts, yeast extracts, natural or synthetic phystosterols, salicylic acid, oligosaccharides, polysaccharides, amino sugars, polyphenols, flavonoids, lipids, phospholipids, cyclic AMP and its derivatives, activator agents of the enzyme adenylate cyclase and inhibiting agents of the enzyme phosphodiesterase, theine, theophylline, theobromine, forskolin, esculin, ACE inhibitors, dioscorea extract, guarana extract, ivy extract, fucus extract, seaweed extracts such as Palmaria Palmata extract, hydrolyzed extract of Prunella vulgaris or elder extract.

5. The cosmetic care method according to claim 1 , wherein said Artemia salina extract is present at a concentration of about 0.01% to about 10% of the total weight of the composition.

6. The cosmetic care method according to claim 1 , wherein topically applying the composition comprises applying about 2 mg/cm 2 .

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2016
From: BUSUTTIL, VALÈRE; CUCUMEL, KARINE; ASTLES, NEIL; DOMLOGE, NOUHA
To: ISP INVESTMENTS INC.
Reel/Frame 039793/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2016
From: BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 038979/0246 →
Priority Claims (1)
FR 14 50132 · Jan 8, 2014 · national
Continuity (1)
Related Publication 20170042802A1 · Feb 16, 2017